IL257057A - Biologically active peptides derived from soy for use in preparations and methods for wound healing, tissue engineering and regenerative medicine - Google Patents

Biologically active peptides derived from soy for use in preparations and methods for wound healing, tissue engineering and regenerative medicine

Info

Publication number
IL257057A
IL257057A IL257057A IL25705718A IL257057A IL 257057 A IL257057 A IL 257057A IL 257057 A IL257057 A IL 257057A IL 25705718 A IL25705718 A IL 25705718A IL 257057 A IL257057 A IL 257057A
Authority
IL
Israel
Prior art keywords
soy
compositions
methods
wound healing
tissue engineering
Prior art date
Application number
IL257057A
Other languages
English (en)
Hebrew (he)
Original Assignee
Univ Temple
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Temple filed Critical Univ Temple
Publication of IL257057A publication Critical patent/IL257057A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/222—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Materials For Medical Uses (AREA)
IL257057A 2015-07-22 2018-01-21 Biologically active peptides derived from soy for use in preparations and methods for wound healing, tissue engineering and regenerative medicine IL257057A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562195386P 2015-07-22 2015-07-22
US201562234266P 2015-09-29 2015-09-29
US201562256480P 2015-11-17 2015-11-17
US201662335195P 2016-05-12 2016-05-12
PCT/US2016/043388 WO2017015488A1 (en) 2015-07-22 2016-07-21 Soy-derived bioactive peptides for use in compositions and methods for wound healing, tissue engineering, and regenerative medicine

Publications (1)

Publication Number Publication Date
IL257057A true IL257057A (en) 2018-03-29

Family

ID=57834763

Family Applications (1)

Application Number Title Priority Date Filing Date
IL257057A IL257057A (en) 2015-07-22 2018-01-21 Biologically active peptides derived from soy for use in preparations and methods for wound healing, tissue engineering and regenerative medicine

Country Status (5)

Country Link
US (3) US11077169B2 (https=)
EP (1) EP3325029B1 (https=)
JP (1) JP2018525360A (https=)
IL (1) IL257057A (https=)
WO (1) WO2017015488A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102228571B1 (ko) * 2017-02-09 2021-03-16 주식회사 메디폴리머 정신질환 또는 중추신경계 질환 치료용 약물전달 제형
CN106913911B (zh) * 2017-02-23 2020-02-18 福建吉特瑞生物科技有限公司 一种用于整形外科的医用胶原膜
CN107290445B (zh) * 2017-05-24 2019-11-05 浙江圣兆药物科技股份有限公司 一种检测注射用微球制剂中乳酸和乙醇酸含量的方法
EP3706718A1 (en) * 2017-11-07 2020-09-16 Royal College of Surgeons in Ireland A thermo-responsive hydrogel for intratumoral administration as a treatment in solid tumor cancers
US20190290283A1 (en) * 2018-03-26 2019-09-26 Wichita State University Composite neural conduit
CN109731126A (zh) * 2019-01-25 2019-05-10 芬森健康科技(广州)中心(有限合伙) 一种具有修复皮肤功能的生物敷料及其制备方法
CN111500063B (zh) * 2019-01-31 2021-12-14 中国科学技术大学 一种聚苯胺导电水凝胶及其制备方法和超级电容器
WO2021067568A1 (en) * 2019-10-01 2021-04-08 The Regents Of The University Of California Soy proteins for preparation of gels, fibers and films
CN111000796A (zh) * 2019-12-31 2020-04-14 瑞希(重庆)生物科技有限公司 一种透明质酸钠凝胶及其制备方法和应用
CN113080365B (zh) * 2021-04-02 2022-12-06 嘉应学院 一种大豆素纳米粉的制备方法及其应用
EP4401799A1 (en) 2021-09-15 2024-07-24 Universidad del País Vasco/Euskal Herriko Unibertsitatea Sponge-like scaffold for promoting haemostasis
CN114470301B (zh) * 2021-12-22 2023-06-09 南京财经大学 大豆多肽可吸收医用缝合线制备方法
CN114533859B (zh) * 2022-02-23 2023-04-25 宁波项谨记百货有限公司 一种治疗痔疮的中药药膏及其制备方法
WO2023212122A1 (en) * 2022-04-27 2023-11-02 Ohayo Valley Inc. Processes and compositions for preparation of whole-cut meat analogues
CN115089767B (zh) * 2022-05-25 2023-06-20 中山大学 一种大豆创伤修复材料及其制备方法与应用
TR2024002381A2 (tr) * 2024-02-28 2024-04-22 Mugla Sitki Kocman Ueniversitesi Strateji Gelistirme Daire Baskanligi Di̇yabeti̇k hastaliğindan müzdari̇p ki̇şi̇ler i̇çi̇n tam yaralarin i̇yi̇leşti̇ri̇lmesi̇ne olanak sağlayan bi̇r kompozi̇syon
TR2024006408A2 (tr) * 2024-05-23 2024-06-21 Mugla Sitki Kocman Ueniversitesi Strateji Gelistirme Daire Baskanligi Deri̇ yaralarinin i̇yi̇leşmesi̇ne olanak sağlayan bi̇r yara örtüsü kompozi̇syonu ve üreti̇mi̇ i̇çi̇n bi̇r yöntem
CN119684437B (zh) * 2024-12-26 2025-09-12 江苏创健医疗科技股份有限公司 一种基于多层过滤的重组胶原蛋白分离纯化方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001944A (en) 1975-08-25 1977-01-11 Parke, Davis & Company Freeze-drying process
US5382431A (en) 1992-09-29 1995-01-17 Skin Biology, Inc. Tissue protective and regenerative compositions
US6541062B2 (en) 1999-12-17 2003-04-01 Mitsunori Ono Water-soluble soybean extracts
EP2093256A3 (en) * 2005-07-28 2009-10-14 Carnegie Mellon University Biocompatible polymers and methods of use
JP5084393B2 (ja) * 2006-07-31 2012-11-28 ロート製薬株式会社 コラーゲン産生促進能及び／又は線維芽細胞増殖促進能を有する組成物
US8790921B2 (en) * 2007-02-14 2014-07-29 Drexel University Alimentary protein-based scaffolds (APS) for wound healing, regenerative medicine and drug discovery
TR201815580T4 (tr) 2007-08-22 2018-11-21 Noveome Biotherapeutics Inc Yaraları iyileştirmeye yönelik çözelti bileşimleri ve bunların kullanımlarını içeren yeni selüler faktör.
US20100111919A1 (en) * 2008-10-31 2010-05-06 Tyco Healthcare Group Lp Delayed gelation compositions and methods of use
WO2012120516A1 (en) * 2011-03-09 2012-09-13 Ramot At Tel-Aviv University Ltd. Soy protein-based structures and uses thereof
JP6153469B2 (ja) * 2011-09-12 2017-06-28 ロート製薬株式会社 ダイズタンパク質の加水分解物を含有する組成物
US20130302896A1 (en) * 2012-03-23 2013-11-14 Northwestern University Soy-protein containing porous materials

Also Published As

Publication number Publication date
US12251420B2 (en) 2025-03-18
JP2018525360A (ja) 2018-09-06
EP3325029A1 (en) 2018-05-30
US20180207232A1 (en) 2018-07-26
WO2017015488A1 (en) 2017-01-26
US11077169B2 (en) 2021-08-03
EP3325029B1 (en) 2023-05-24
US20250295731A1 (en) 2025-09-25
EP3325029A4 (en) 2019-02-27
US20220211804A1 (en) 2022-07-07

Similar Documents

Publication Publication Date Title
IL257057A (en) Biologically active peptides derived from soy for use in preparations and methods for wound healing, tissue engineering and regenerative medicine
IL256085B (en) A converted derivative of huanic acid, a pharmaceutical preparation containing it and the converted derivative for use in treatment
IL257358B (en) Methods and pharmaceutical compositions for improving wound healing using cd24
IL235923B (en) Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical preparations thereof
LT3378859T (lt) Benzofurano darinys, jo gavimo būdas ir jo panaudojimas medicinoje
EP2986229A4 (en) METHODS, DEVICES AND THERAPEUTIC PLATFORM FOR SELECTING AND AUTOMATED MOLD TISSUE RESECTION
EP3331459A4 (en) DEVICES, SYSTEMS, AND METHODS OF COLLECTION FOR USE IN BONE TISSUE
IL258246B (en) Isolidine compound, pharmaceutical compositions comprising same, their combinations with therapeutic agents for use in the treatment of cancer
EP3185905A4 (en) Compositions and methods for enhancing healing and regeneration of bone and soft tissue
IL273470A (en) Semaglutide in medical treatment
SG11201605868XA (en) Pharmaceutical composition for cancer treatment and pharmaceutical preparation for cancer treatment containing same composition as active ingredient
EP3318879A4 (en) Gpc3-targeted therapeutic agent administered to patient in whom gpc3-targetd therapeutic ag
ZA201505670B (en) Pharmaceutical compositions for treating thermal injuries and wounds combined with bone injuries
IL251351B (en) Preparations for use in the treatment and prevention of surgical infections
PH12016502243A1 (en) Pharmaceutical compositions for treating infectious diseases
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
GB201503967D0 (en) Biocompatible implants for use in tendon therapy
PL3129057T3 (pl) Glikolipidy i ich kompozycje farmaceutyczne do stosowania w leczeniu
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
IL280389A (en) Bile acid receptor modulators conjugated to G.1 protein and methods of using them
IL249860A0 (en) Pharmaceutical preparations, methods for their preparation and their use for the treatment of cancer
SG11201701939UA (en) Cosmetic and/or pharmaceutical composition in the form of a dispersion, method for preparing same and use thereof for skin treatment
PL3341481T3 (pl) Kompozycja antysensowna mikrorna-328 i zastosowanie terapeutyczne
GB201519644D0 (en) Therapy and pharmaceutical composition
IL237283A0 (en) Dldh and its derivatives, and preparations containing them for medical use